1-3 of 3
Pavla Stepankova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Can Circulating Tumor DNA Improve the Predictive Value of Interim Response in Patients with Advanced Hodgkin Lymphoma and PET-2 DS3?

Heidi Mocikova, Kristyna Kupcova, Jana Markova, Lubica Gaherova, Maria Maco, Iva Hamova, Adriana Velasova, Alice Sykorova, Pavla Stepankova, Alexandra Kredatusova, Vit Prochazka, Jan Koren, Petr Nehasil, Petra Zemankova, Tomas Kozak, Ondrej Havranek
Journal: Blood
Blood (2024) 144 (Supplement 1): 6193.
https://doi.org/10.1182/blood-2024-210890
Published: 2024
Journal Articles

Elderly Hodgkin Lymphoma - Multicenter Retrospective Data Analysis from the Czech Hodgkin Lymphoma Registry

Alice Sýkorová, MD PhD, Heidi Mocikova, MD PhD, Vit Prochazka, MD PhD Assoc Prof, Marie Lukasova, MD, Pavla Stepankova, MD, David Belada, MD PhD, Katerina Klaskova, MA, Lubica Gaherova, MD, Karel Chroust, MA, PhD, Jana Markova, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2792.
https://doi.org/10.1182/blood.V130.Suppl_1.2792.2792
Published: 2017
Journal Articles

Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated with or without Rituximab

Heidi Mocikova, MD, PhD, Jozef Michalka, MD, Jan Koren, Pavla Stepankova, Alexander Wild, Ludek Raida, MD, Jana Markova, MD, Zdenek Kral, Marek Trneny, MD, Karel Indrak, MD, Prof., Jiri Mayer, M.D., PhD., Prof., Tomas Kozak, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 4878.
https://doi.org/10.1182/blood.V120.21.4878.4878
Published: 2012